Molecular docking is essential in bioinformatics for drug discovery, enabling the prediction of binding orientation and affinity of drug candidates to target proteins. It facilitates virtual screening of large compound databases, enriches understanding of protein-ligand interactions, and aids in lead optimization. Additionally, it supports fragment-based drug design, in silico mutagenesis studies, and pharmacophore modeling.